编辑信息

Trinseo Webinar: Acrylonitrile Butadiene Styrene (ABS) for Medical Devices

Agenda includes applications using ABS and the difference in production methods

BERWYN, Pa. - Tuesday, July 10, 2018

Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, will discuss ABS resins for medical applications at its upcoming webinar on July 11, 2018 at 10:00 am EST. This is part of Trinseo’s webinar series designed to educate the marketplace on polymer technology and related topics.

Customers, media, and the general public can register now.

Trinseo has been providing polymers to global medical device manufacturers for nearly three decades and supports single and multiple use medical devices, drug delivery systems, and medical equipment housings with material solutions. The company has seen an increase in the use of ABS for medical devices because of benefits including processability, aesthetics, colorability, and toughness as well as potential customer cost savings opportunities.

Trinseo offers its ABS under the MAGNUM™ ABS Resins brand. MAGNUM™ ABS is distinct due to its mass polymerization technology that results in an exceptionally white base color, low gel levels, and low residual Volatile Organic Compounds (VOCs).These properties are especially critical in the medical devices sector where purity, quality of color, and surface finish are key.

Besides MAGNUM ABS Resins, Trinseo offers CALIBRE Polycarbonate Resins, EMERGE Advanced Resins, and STYRON Polystyrene Resins. Trinseo has a full portfolio of medical grade resins that have been tested for biocompatibility according to ISO 10993.

Trinseo is committed to quality and customers’ compliancy requirements in the highly-regulated medical space. Its medical manufacturing and compounding facilities at Stade, Germany, Hsinchu, Taiwan, and in North America as well as related global functions are ISO 13485:2016 certified with the latest 2016 version focused on risk management and process validation.

About Trinseo

Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber with a focus on delivering innovative, sustainable, and value-creating products that are intrinsic to our daily lives. Trinseo is dedicated to making a positive impact on society by partnering with like-minded stakeholders, and supporting the sustainability goals of our customers in a wide range of end-markets including automotive, consumer electronics, appliances, medical devices, packaging, footwear, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.0 billion in net sales in 2020, with 17 manufacturing sites around the world, and approximately 2,600 employees. For more information, please visit: www.trinseo.com.

Cautionary Note on Forward-Looking Statements

This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding the timing of the proposed acquisition of the Arkema MMA and PMMA business (the "Acquisition"); estimated and future results of operations, business strategies, competitive position, industry environment and potential growth opportunities and cost synergies relating to the Acquisition, our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause such a difference include, but are not limited to, our failure to complete the Acquisition or meet the conditions to closing, including antitrust, works council and other regulatory approvals; the failure to obtain the financing necessary to fund the Acquisition and the impact of the substantial indebtedness to be incurred; costs related to the Acquisition; following the Acquisition, our ability to successfully integrate the acquired businesses, generate expected cost savings and synergies, maintain relationships with customers, retain key employees and profitably grow the business; and those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

编辑信息

接收盛禧奥独家内容

方便地通过电子邮件抢先了解新产品信息、公司新闻及其它盛禧奥资讯动态!